Recent advances in nonalcoholic fatty liver disease - PubMed
Review
Recent advances in nonalcoholic fatty liver disease
Onpan Cheung et al. Curr Opin Gastroenterol. 2010 May.
Abstract
Purpose of review: This review focuses on recent advances in the study of the epidemiology, pathogenesis, natural history and treatment of nonalcoholic fatty liver disease (NAFLD).
Recent findings: Study of hepatic lipid metabolism, insulin resistance, mitochondrial dysfunction and oxidative stress, genetic variants and predisposition to altered metabolism and cell injury have contributed to our current understanding of NAFLD. Differential expression of microRNA in fatty liver and its implication in disease pathogenesis and therapeutic potential have continued to advance over the year. The pathogenesis of hepatocellular carcinoma in steatohepatitis continues to be explored. The diagnostic utility of imaging and noninvasive markers seems promising in estimating the severity of steatosis and fibrosis. Liver biopsy remains the gold standard for accurately assessing NAFLD and steatohepatitis. Lifestyle modification and weight loss improve both metabolic profile and liver histology. Pharmacotherapy for the treatment of NAFLD remains lacking.
Summary: The underlying mechanism and pathogenesis of NAFLD remain elusive despite ongoing researches to make significant advances in the understanding of its natural history, pathogenesis and management. Pharmacotherapy has yet to indicate a promising therapeutic intervention. Current treatment focuses on managing underlying cardio-metabolic risks.
Similar articles
-
[Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH. Park SH. Korean J Hepatol. 2008 Mar;14(1):12-27. doi: 10.3350/kjhep.2008.14.1.12. Korean J Hepatol. 2008. PMID: 18367854 Review. Korean.
-
Milić S, Stimac D. Milić S, et al. Dig Dis. 2012;30(2):158-62. doi: 10.1159/000336669. Epub 2012 Jun 20. Dig Dis. 2012. PMID: 22722431 Review.
-
Nonalcoholic fatty liver disease.
Hjelkrem MC, Torres DM, Harrison SA. Hjelkrem MC, et al. Minerva Med. 2008 Dec;99(6):583-93. Minerva Med. 2008. PMID: 19034256 Review.
-
Carter-Kent C, Zein NN, Feldstein AE. Carter-Kent C, et al. Am J Gastroenterol. 2008 Apr;103(4):1036-42. doi: 10.1111/j.1572-0241.2007.01709.x. Epub 2008 Jan 2. Am J Gastroenterol. 2008. PMID: 18177455 Review.
-
Nonalcoholic fatty liver disease as a complication of insulin resistance.
Abdelmalek MF, Diehl AM. Abdelmalek MF, et al. Med Clin North Am. 2007 Nov;91(6):1125-49, ix. doi: 10.1016/j.mcna.2007.06.001. Med Clin North Am. 2007. PMID: 17964913 Review.
Cited by
-
Resistin expression correlates with steatohepatitis in morbidly obese patients.
Edwards CR, Hindle AK, Latham PS, Fu SW, Brody FJ. Edwards CR, et al. Surg Endosc. 2013 Apr;27(4):1310-4. doi: 10.1007/s00464-012-2603-y. Epub 2012 Dec 12. Surg Endosc. 2013. PMID: 23233000
-
Zhang Y, Wang C, Lu J, Jin Y, Xu C, Meng Q, Liu Q, Dong D, Ma X, Liu K, Sun H. Zhang Y, et al. Aging (Albany NY). 2020 Feb 5;12(3):2049-2069. doi: 10.18632/aging.102721. Epub 2020 Feb 5. Aging (Albany NY). 2020. PMID: 32023549 Free PMC article.
-
Cantley JL, Yoshimura T, Camporez JP, Zhang D, Jornayvaz FR, Kumashiro N, Guebre-Egziabher F, Jurczak MJ, Kahn M, Guigni BA, Serr J, Hankin J, Murphy RC, Cline GW, Bhanot S, Manchem VP, Brown JM, Samuel VT, Shulman GI. Cantley JL, et al. Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1869-74. doi: 10.1073/pnas.1219456110. Epub 2013 Jan 9. Proc Natl Acad Sci U S A. 2013. PMID: 23302688 Free PMC article.
-
Ding C, Zhao Y, Shi X, Zhang N, Zu G, Li Z, Zhou J, Gao D, Lv L, Tian X, Yao J. Ding C, et al. Sci Rep. 2016 Jun 27;6:28734. doi: 10.1038/srep28734. Sci Rep. 2016. PMID: 27345365 Free PMC article.
-
Liu W, Baker SS, Baker RD, Nowak NJ, Zhu L. Liu W, et al. PLoS One. 2011;6(9):e24363. doi: 10.1371/journal.pone.0024363. Epub 2011 Sep 12. PLoS One. 2011. PMID: 21931690 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials